Stroke Risk, Stent Benefit, Surgical Uncertainty 🧠✨🔧

New NEJM insights on asymptomatic carotid stenosis 🧠🔍   The CREST-2 trials offer a landmark update: intensive medical therapy remains the cornerstone, while carotid stenting shows selective benefit when performed by expert operators. Endarterectomy, however, provides no significant advantage over modern medical management.   With stricter blood-pressure and LDL targets, plus expanding use of PCSK9 inhibitors, the future of stroke prevention is increasingly precision-driven, medically optimized, and patient-centered. 💊📉✨   A thoughtful read for all involved in vascular care, cerebrovascular prevention, and clinical decision-making. 📘🫀